Plain-English translation of NCT02732171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study asks breast cancer survivors who finished treatment within the past 5 years to donate a bone marrow sample. Doctors will test these samples for rare cancer cells that may have spread to the bone marrow before symptoms appear. If cancer cells are found, you may be offered enrollment in a separate trial testing treatments designed to prevent recurrence.
Some breast cancer patients are at higher risk of their cancer returning, even after completing standard treatment. This study aims to find an early warning sign — the presence of cancer cells in bone marrow — that could help doctors identify who needs additional preventive therapy before cancer comes back.
You likely qualify if…
You likely don't qualify if…
You will visit the study center for a bone marrow aspiration — a procedure where doctors use a needle to collect a small sample of bone marrow, usually from your hip bone. Blood samples will also be collected for research testing. The bone marrow and blood will be analyzed to look for disseminated tumor cells. If cancer cells are found, you will be offered the opportunity to enroll in a separate clinical trial testing preventive therapy. If no cancer cells are detected, your participation in this screening study is complete.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States